# SERTRALINE HYDROCHLORIDE
> **ANDA220275** · Abbreviated New Drug Application (Generic) · Sponsor: ZYDUS LIFESCIENCES · Approved 2026-01-29
## Drug
- **FDA Application Number:** ANDA220275
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** SERTRALINE HYDROCHLORIDE
- **Generic name:** SERTRALINE HYDROCHLORIDE
- **Active ingredients:** SERTRALINE HYDROCHLORIDE
- **Dosage form:** CAPSULE
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** ZYDUS LIFESCIENCES
- **Manufacturer:** Zydus Pharmaceuticals (USA) Inc.
- **First approval:** 2026-01-29
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=220275)
---
*MORVS · CC0 1.0*